Sun Pharmaceutical Industries consolidated net profit soared 11.13% to Rs 2,058.80 crore on a 11.61% surge in total revenue from operations to Rs 9,863.06 crore in Q3 December 2021 over Q3 December 2020.
The Company is an India-based company that is engaged in the business of trading in ferrous and non-ferrous metal scrap.
India is expected to see an 8% to 8.5% GDP growth in the financial year 2022-23, according to Economic Survey 2022. Private sector investment to pick with financial system in good position to provide support to revival of economy. Robust export growth and availability of fiscal space to ramp up capital spending to support growth next fiscal. Growth in FY23 to be supported by widespread […]
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
